Cargando…
Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Prostate Cancer
Introduction Many men receiving temporary androgen deprivation therapy (ADT) for localized prostate cancer fail to achieve baseline testosterone levels after cessation. Testosterone recovery in men with localized prostate cancer receiving temporary ADT was assessed. Methods A global federated health...
Autores principales: | Delgado, Jessica, Ory, Jesse, Loloi, Justin, Deebel, Nicholas A, Bernstein, Ari, Nackeeran, Sirpi, Zucker, Isaac, Ramasamy, Ranjith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9848702/ https://www.ncbi.nlm.nih.gov/pubmed/36686106 http://dx.doi.org/10.7759/cureus.32699 |
Ejemplares similares
-
Efficacy and safety outcomes of a compounded testosterone pellet versus a branded testosterone pellet in men with testosterone deficiency: a single-center, open-label, randomized trial
por: Kresch, Eliyahu, et al.
Publicado: (2023) -
Factors Associated With Restarting Androgenic Anabolic Steroids After Cessation in Men With Infertility: A Retrospective Analysis
por: White, Josh, et al.
Publicado: (2023) -
Do Women Have a Seat at the Table: Trends in Female Representation Among the Board of Directors in American Urological Association Subspecialty Societies
por: Dullea, Alexandra D, et al.
Publicado: (2022) -
Impact of Short-Acting vs Long-Acting Testosterone Therapy on Intratesticular Testosterone Using Data From Two Open-Label Randomized Clinical Trials of Testosterone Pellets, Injections, and Intranasal Gel in Hypogonadal Men
por: Kresch, Eliyahu, et al.
Publicado: (2021) -
Efficacy and Safety of Human Chorionic Gonadotropin Monotherapy for Men With Hypogonadal Symptoms and Normal Testosterone
por: Zucker, Isaac, et al.
Publicado: (2022)